| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 3.53e-03 | 679 | 18 | 4 | 3.30.160.60 | |
| Domain | zf-C2H2 | 3.79e-03 | 693 | 18 | 4 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.81e-03 | 694 | 18 | 4 | IPR013087 | |
| Domain | KRAB | 4.60e-03 | 358 | 18 | 3 | PS50805 | |
| Domain | KRAB | 4.60e-03 | 358 | 18 | 3 | PF01352 | |
| Domain | KRAB | 5.01e-03 | 369 | 18 | 3 | SM00349 | |
| Domain | KRAB | 5.04e-03 | 370 | 18 | 3 | IPR001909 | |
| Domain | ZINC_FINGER_C2H2_2 | 5.65e-03 | 775 | 18 | 4 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 5.70e-03 | 777 | 18 | 4 | PS00028 | |
| Domain | Znf_C2H2-like | 6.21e-03 | 796 | 18 | 4 | IPR015880 | |
| Domain | Znf_C2H2 | 6.46e-03 | 805 | 18 | 4 | IPR007087 | |
| Domain | ZnF_C2H2 | 6.55e-03 | 808 | 18 | 4 | SM00355 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 27793841 | ||
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 26122663 | ||
| Cytoband | 19q13.12 | 3.65e-04 | 72 | 18 | 2 | 19q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.46e-04 | 718 | 12 | 4 | 28 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 3.88e-05 | 79 | 18 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_100 | 7.86e-05 | 100 | 18 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 9.88e-05 | 108 | 18 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 18 | 3 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-05 | 179 | 18 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 186 | 18 | 3 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 188 | 18 | 3 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.77e-05 | 190 | 18 | 3 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.86e-05 | 191 | 18 | 3 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.43e-05 | 197 | 18 | 3 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.52e-05 | 198 | 18 | 3 | 90ebefc9ba8dc2a81471e5693384f5ce56f06298 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.72e-05 | 200 | 18 | 3 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.34e-03 | 136 | 18 | 2 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 1.42e-03 | 140 | 18 | 2 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-03 | 145 | 18 | 2 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.55e-03 | 146 | 18 | 2 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 151 | 18 | 2 | a306e8dac653bc785d805d8d2d94feec3cb01727 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-03 | 155 | 18 | 2 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-03 | 155 | 18 | 2 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-03 | 156 | 18 | 2 | 841d653d74c4de41d2f9a114f6ccb92d6a1ebc24 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.76e-03 | 156 | 18 | 2 | a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-03 | 160 | 18 | 2 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 160 | 18 | 2 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 162 | 18 | 2 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | 11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.92e-03 | 163 | 18 | 2 | 31b60e065bac4ad380247964e7574f210106ebae | |
| ToppCell | 11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.92e-03 | 163 | 18 | 2 | e9d814952d824539ff1dea119e4fca14a8c335a8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.92e-03 | 163 | 18 | 2 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-03 | 164 | 18 | 2 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.97e-03 | 165 | 18 | 2 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-03 | 165 | 18 | 2 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 1.99e-03 | 166 | 18 | 2 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.99e-03 | 166 | 18 | 2 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 1.99e-03 | 166 | 18 | 2 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-03 | 167 | 18 | 2 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.04e-03 | 168 | 18 | 2 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-03 | 169 | 18 | 2 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-03 | 169 | 18 | 2 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.06e-03 | 169 | 18 | 2 | 7b71463f0fd802b422c8d394a435901009ca200f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-03 | 169 | 18 | 2 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.09e-03 | 170 | 18 | 2 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.09e-03 | 170 | 18 | 2 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.09e-03 | 170 | 18 | 2 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-03 | 171 | 18 | 2 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-03 | 171 | 18 | 2 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 171 | 18 | 2 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 171 | 18 | 2 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-03 | 172 | 18 | 2 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-03 | 172 | 18 | 2 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 2.16e-03 | 173 | 18 | 2 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-03 | 174 | 18 | 2 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-03 | 174 | 18 | 2 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-03 | 174 | 18 | 2 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.21e-03 | 175 | 18 | 2 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-03 | 175 | 18 | 2 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.23e-03 | 176 | 18 | 2 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-03 | 176 | 18 | 2 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_THEMIS_ELOF1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-03 | 176 | 18 | 2 | 78306517b1e52411a2ba72f141efea4d12c09f25 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-03 | 176 | 18 | 2 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pre-pDC/DC5|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.26e-03 | 177 | 18 | 2 | 6de3c623f8595d7e3827df99b806bc9f1f15b3b7 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.26e-03 | 177 | 18 | 2 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 2.26e-03 | 177 | 18 | 2 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 2.28e-03 | 178 | 18 | 2 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-03 | 178 | 18 | 2 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-03 | 178 | 18 | 2 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-03 | 178 | 18 | 2 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-03 | 178 | 18 | 2 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-03 | 179 | 18 | 2 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-03 | 179 | 18 | 2 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-03 | 179 | 18 | 2 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.31e-03 | 179 | 18 | 2 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-03 | 179 | 18 | 2 | b8ca29aebd25ebac441bebd769bbf98c536d3166 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 180 | 18 | 2 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 2.33e-03 | 180 | 18 | 2 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-03 | 180 | 18 | 2 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-03 | 180 | 18 | 2 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 180 | 18 | 2 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-03 | 180 | 18 | 2 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 180 | 18 | 2 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-03 | 181 | 18 | 2 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-03 | 181 | 18 | 2 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-03 | 181 | 18 | 2 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-03 | 181 | 18 | 2 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-03 | 181 | 18 | 2 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-03 | 181 | 18 | 2 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.36e-03 | 181 | 18 | 2 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-03 | 182 | 18 | 2 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-03 | 182 | 18 | 2 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-03 | 182 | 18 | 2 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.41e-03 | 183 | 18 | 2 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.41e-03 | 183 | 18 | 2 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 2.41e-03 | 183 | 18 | 2 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-03 | 183 | 18 | 2 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-03 | 183 | 18 | 2 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-03 | 184 | 18 | 2 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-03 | 184 | 18 | 2 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-03 | 184 | 18 | 2 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.25e-06 | 185 | 17 | 4 | 4707_UP | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.62e-04 | 171 | 17 | 3 | 991_UP | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.46e-04 | 188 | 17 | 3 | 3770_DN | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.51e-04 | 189 | 17 | 3 | 3165_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.68e-04 | 192 | 17 | 3 | 5567_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 3.74e-04 | 193 | 17 | 3 | 997_UP | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 6646_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 6368_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 6173_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 3114_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 2445_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 2440_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 2240_UP | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 4130_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 4570_DN | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 3331_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6363_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3694_UP | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4177_DN | |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5043_UP | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2704_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2573_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2558_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2061_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3209_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5102_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6446_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2768_UP | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3023_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2_UP | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5858_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3810_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3750_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3130_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 2537_UP | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6452_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 5384_UP | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6675_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 2679_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 3058_DN | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6462_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 2190_UP | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 3795_UP | |
| Disease | tyrosine measurement | 2.79e-05 | 104 | 17 | 3 | EFO_0005058 | |
| Disease | age at assessment, lateral ventricle volume change measurement | 1.09e-04 | 27 | 17 | 2 | EFO_0008007, EFO_0021502 | |
| Disease | brain connectivity measurement | 1.46e-03 | 400 | 17 | 3 | EFO_0005210 | |
| Disease | glycoprotein measurement | 2.11e-03 | 119 | 17 | 2 | EFO_0004555 | |
| Disease | glycine measurement | 2.78e-03 | 137 | 17 | 2 | EFO_0009767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHSHIYELAYISSHS | 3571 | Q8WXG9 | |
| HCQYYSHNHSSEYSD | 96 | Q8N149 | |
| ANYHSSNAYHNSTHA | 606 | O95263 | |
| AAYSHHYSKSDTQTH | 601 | Q9H0J9 | |
| HAKHHTSEAIESYYQ | 56 | Q9Y2V0 | |
| DHSYQHLSSHAQYSC | 81 | A8K830 | |
| NSSGHYQYHTVHKDS | 371 | Q8WUM9 | |
| TTTAHATLTGLHYYH | 271 | Q9BPU6 | |
| DSTSSYFNHYRSHHN | 581 | Q13393 | |
| SAAHTHSNTYNFTKS | 926 | P25054 | |
| NDYTHTSYNAMHVKH | 296 | Q8IUQ0 | |
| EHTSVTYNHEKAHSY | 211 | Q8TC36 | |
| SSKSSHSHHLQFFYA | 2301 | Q6N022 | |
| HSETNVHDESHFSYS | 851 | Q86YV5 | |
| KSSHIFSHHSYFTEQ | 566 | Q6PG37 | |
| FSHHSYFTEQKIHNS | 571 | Q6PG37 | |
| FTEYSSLYKHHVVHT | 326 | P36508 | |
| GKAFSYHSSFSHHQK | 391 | Q8TAF7 | |
| SSYSHHENTHTGVKF | 231 | P51508 | |
| STESYPYKHSHHESV | 396 | Q70EL1 |